TY  - CONF

T1  - Dosing of zoledronic acid (ZOL) throughout the treatment continuum in patients (pts) with breast cancer (BC)

JO  - BREAST

PY  - 2009/03/01

AU  - Hadji P

AU  - Gnant M

AU  - Aapro M

AU  - Lipton A

AU  - Coleman R

ED  - 

VL  - 18

SP  - S60

EP  - S60

Y2  - 2025/10/10

ER  -